Institutional investors purchased a net $13.2 million shares of GSK during the quarter ended December 2014 and now own 10.60% of the total shares outstanding. This is a greater percentage than is typical for companies in the Pharmaceuticals: Major industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
LOCUST WOOD CAPITAL ADVISERS LLC Bought 401.4 Thousand shares of GlaxoSmithKline